Related references
Note: Only part of the references are listed.A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study
Sheri L. Spunt et al.
LANCET ONCOLOGY (2020)
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial
Aaron R. Weiss et al.
LANCET ONCOLOGY (2020)
Tumor necrosis and clinical outcomes following neoadjuvant therapy in soft tissue sarcoma: A systematic review and meta-analysis
Samer Salah et al.
CANCER TREATMENT REVIEWS (2018)
Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience
Daniel Orbach et al.
CANCER MEDICINE (2018)
The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials
Sabine Stegmaier et al.
PEDIATRIC BLOOD & CANCER (2017)
Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children's Oncology Group
Andrea Ferrari et al.
EUROPEAN JOURNAL OF CANCER (2017)
Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity
Myrella Vlenterie et al.
EUROPEAN JOURNAL OF CANCER (2016)
Primary Metastatic Synovial Sarcoma: Experience of the CWS Study Group
Monika Scheer et al.
PEDIATRIC BLOOD & CANCER (2016)
Age as an independent prognostic factor for survival of localised synovial sarcoma patients
Myrella Vlenterie et al.
BRITISH JOURNAL OF CANCER (2015)
Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)
A. Ferrari et al.
ANNALS OF ONCOLOGY (2015)
Grossly-resected synovial sarcoma treated by the German and Italian pediatric soft tissue sarcoma cooperative groups: Discussion on the role of adjuvant therapies
IB Brecht et al.
PEDIATRIC BLOOD & CANCER (2006)
Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: A pediatric oncology group study
AS Pappo et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Synovial sarcoma of childhood and adolescence: A multicenter, multivariate analysis of outcome
MF Okcu et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Treatment-induced pathologic necrosis: A predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas
FC Eilber et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
